Cachexia is a devastating, multifactorial and often irreversible systemic syndrome
characterized by substantial weight loss (mainly of skeletal muscle and adipose tissue) that …

Low muscle mass and malnutrition are prevalent conditions among adults of all ages, with
any body weight or body mass index, and with acute or chronic conditions, including COVID …

Low muscle mass is prevalent among patients with cancer and a predictor of adverse
clinical outcomes. To counteract muscle loss, β‐hydroxy β‐methylbutyrate (HMB) …

Sarcopenia is a geriatric condition characterized by a progressive loss of skeletal muscle
mass and strength, with an increased risk of adverse health outcomes (eg, falls, disability …

Introduction Cancer cachexia is a multifactorial metabolic syndrome associated with a
pathophysiology intertwined with increased inflammatory response, anorexia, metabolic …

Intermittent (or bolus) feeding regimens in critically ill patients have been of increasing
interest to clinicians and scientists. Changes in amino acid, fat and carbohydrate metabolites …

The association between the systemic immune-inflammation index (SII) and the risk of
sarcopenia has not yet been revealed. The purpose of this study was to investigate the …

Introduction: Malnutrition is a widespread and intricate issue among hospitalized adults,
necessitating a wide variety of nutritional strategies to address its root causes and …

l-Anserine, an imidazole peptide, has a variety of physiological activities, but its effects on
skeletal muscle differentiation and muscle contractile force remain unknown. Thus, in this …

Cachexia is a commonly observed but frequently neglected extra-pulmonary manifestation
in patients with chronic obstructive pulmonary disease (COPD). Cachexia is a multifactorial …